Obstetrics & gynecology
Women’s health & pregnancy clinical trials
Reproductive health, pregnancy, and conditions specific to women. We’re tracking 6,071 recruiting studies in this area right now.
By phase
- Not applicable4,173
- Phase 2598
- Phase 1413
- Phase 3326
- Phase 4250
- Phase 1/Phase 2245
- Phase 2/Phase 366
Top conditions
- Ovarian Cancer335
- Cervical Cancer222
- Endometrial Cancer205
- Bladder Cancer186
- Acute Kidney Injury133
- Endometriosis131
- Pregnancy128
- Chronic Kidney Diseases123
- Breast Cancer110
- Chronic Kidney Disease107
- Infertility92
- Renal Cell Carcinoma80
- Colorectal Cancer77
- Preeclampsia71
- Prostate Cancer68
- Pregnancy Related65
- Hypertension60
- Urinary Incontinence60
Leading sponsors
- Mayo Clinic60
- IRCCS Azienda Ospedaliero-Universitaria di Bologna47
- M.D. Anderson Cancer Center45
- Assistance Publique - Hôpitaux de Paris44
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS44
- National Cancer Institute (NCI)41
- AstraZeneca38
- University of Colorado, Denver37
- University of Aarhus35
- Chinese University of Hong Kong33
Where studies are running
- California347
- Alabama153
- Texas119
- Massachusetts117
- New York114
- Arizona106
- Florida104
- Maryland88
- Colorado85
- Illinois79
Recruiting studies6,071 total
- NCT02010814Recruiting
Study women with PCOS who are not pregnant
This study follows women with PCOS (a hormone-related condition that can affect periods and other body functions). It’s for women who are not pregnant, helping researchers better understand PCOS over time.
OdenseAges 18–45 - NCT02429700RecruitingPhase 3
Chemo comparison for certain ovarian tumors after surgery
This Phase 3 trial tests two chemotherapy regimens (TC vs BEP) for women with malignant sex cord-stromal tumors of the ovary. It aims to see which treatment works better after you’ve had initial surgery to diagnose and/or remove tumor.
Jinan, ShandongAges 14–65 - NCT02429687RecruitingPhase 3
Testing two chemo regimens for ovarian germ cell tumors
This Phase 3 trial compares two different chemotherapy approaches for women with ovarian sex cord–stromal germ cell tumors. It aims to see which treatment works better and is safer for newly diagnosed stage IIA to IVB disease after surgery.
Jinan, ShandongAges 14–65 - NCT03275194RecruitingPhase 2
HIPEC during interval surgery for advanced ovarian cancer
This trial looks at whether a heated chemotherapy treatment given in the abdomen during a planned second surgery (HIPEC) can improve outcomes for certain advanced ovarian cancers. It is for people who have already had initial chemotherapy and partially responded, with enough health to safely undergo surgery.
Mexico CityAges 18–70 - NCT05817903RecruitingPhase 2
Nivolumab with or without axitinib after prior nivolumab
This Phase 2 trial studies whether adding axitinib to nivolumab (or giving nivolumab alone) can better control advanced clear-cell kidney cancer after standard initial treatment with nivolumab plus ipilimumab. It may help by extending response or slowing tumor growth while improving how long treatment works.
BresciaAges 18 years+ - NCT04583254RecruitingPhase 2
Shorter radiation plan for certain early cervical cancers
This trial tests a feasibility (“can it be done safely?”) approach that delivers radiation in a shorter schedule for some cervical cancer patients. It also uses weekly cisplatin chemotherapy and includes a radiation procedure called brachytherapy to improve treatment effectiveness.
Kelowna, British ColumbiaAges 18 years+ - NCT02610179Recruiting
Testing a candy-based sugar drink screen for gestational diabetes
This study tests whether a candy “sugar twist” drink can be used instead of the usual glucose screening test to find gestational diabetes during pregnancy. It may help make screening easier, but whether you can join depends on your pregnancy timing and prior diabetes risk results.
Houston, TexasAges 18–64 - NCT05367089RecruitingPhase 3
Honey treatment for frequent vaginal yeast infections
This Phase 3 study tests a medical-grade honey product (L-Mesitran) to reduce symptoms from recurrent vaginal yeast infections. If you have frequent episodes, the honey treatment may help lower symptom flare-ups compared with usual care.
HeerlenAges 18 years+ - NCT05766475Recruiting
In-person vs virtual postpartum depression prevention groups
This study compares two ways of delivering a group program to help prevent postpartum depression—either in person or online. If you’re pregnant and speak English or Spanish, you may be able to join the program and help researchers learn which format works best.
Denver, ColoradoAges 18 years+ - NCT05862740Recruiting
Surgery study for advanced ovarian cancer after chemotherapy
This study looks at how well a minimally invasive surgery (laparoscopic debulking) can remove tumor in people with advanced epithelial ovarian cancer. It may help doctors compare whether this approach is safe and effective for patients who need either upfront surgery or surgery after chemotherapy.
Padova, Padova, VenetoAges 18 years+ - NCT05251883Recruiting
Study of data from metastatic ovarian cancer using multiple tests
This study looks at metastatic ovarian cancer by analyzing many types of patient data (from “multi-omics,” which means different kinds of lab and biological information). It may help doctors better understand the disease and improve future care.
Guangzhou, GuangdongAges 18 years+ - NCT05872724RecruitingPhase 2
Personalized add-on treatment after cervical cancer surgery
This study tests whether a tailored “extra” treatment after surgery—guided by a lab test called minimal residual disease (MRD)—can reduce the risk of cervical cancer coming back. It focuses on people with certain stages of cervical cancer who can follow the treatment plan and study follow-up.
Suzhou, JiangsuAges 18 years+ - NCT05606692RecruitingPhase 4
Propofol vs sevoflurane anesthesia in ovarian tumor surgery
This trial compares two types of anesthesia medicines—propofol and sevoflurane—during planned surgery for primary ovarian tumors. It looks at how these anesthetics may affect outcomes in people having elective brain surgery related to ovarian cancer treatment planning.
Kaohsiung CityAges 20–80 - NCT04602962Recruiting
Fertility treatments and fertility preservation study
This study looks at how safe and effective fertility treatments are and how well fertility preservation options work. It is meant for people who are struggling to get pregnant or who need to protect their future fertility.
StockholmAges Up to 56 years - NCT05127252Recruiting
Study how gut bacteria may affect time to pregnancy
This study looks at whether differences in the gut (microbiome) are linked to how long it takes to get pregnant and pregnancy outcomes. It may help researchers understand who might benefit from future microbiome-focused approaches.
Stockholm, HuddingeAges 18–40 - NCT05888909Recruiting
Tests better diagnosis and treatment planning for kidney disease in type 2 diabetes
This trial focuses on improving how kidney damage is diagnosed and how treatment is planned for people with type 2 diabetes and kidney disease. It may help by using detailed medical history and (if done) kidney biopsy results to guide care more accurately.
BeijingAges 18 years+ - NCT05890092Recruiting
Study of vulvar diseases in Nigeria
This is an observational study that looks at vulvar conditions in people assigned female at birth in Nigeria. It does not test a new treatment—researchers mainly want to learn about different vulvar diseases and who gets them.
LondonAges 10–90 - NCT04519151RecruitingPhase 2
Pembrolizumab plus lenvatinib for ovarian cancer that returned
This Phase 2 trial tests whether pembrolizumab plus lenvatinib can shrink ovarian cancer that has come back after platinum chemotherapy. You may be eligible if your cancer returned after a certain “time off” from prior treatment and you meet key health and safety requirements.
Ramat GanAges 18 years+ - NCT04370496Recruiting
Testing minimally invasive endoscopic stapler surgery for early cervix cancer
This trial tests how safe a specific minimally invasive surgery tool (an endoscopic stapler) is for people with early-stage cervical cancer. If you qualify, you would get surgery to remove the cervix area using a minimally invasive approach and the study will track safety outcomes.
SeoulAges 20 years+ - NCT05912972Recruiting
Registry study for women with gynecologic cancers
This is a research study that builds a registry (a record) of women in Korea with cervical, endometrial, or ovarian cancer. It may help researchers better understand these cancers and plan future studies.
SeoulAges 18 years+ - NCT05871853Recruiting
Improving breastfeeding support right after birth
This trial looks at ways to help breastfeeding start and go more smoothly for new moms and babies. It is designed for families giving birth at Slagelse Hospital, and it may offer added support during the early days after delivery.
SlagelseAges 15–100 - NCT05753839Recruiting
Testing surgery plus immunotherapy for metastatic kidney cancer
This trial studies whether removing the kidney tumor (cytoreductive nephrectomy) before treatment can improve outcomes for people with metastatic clear-cell kidney cancer. All participants are expected to receive standard immunotherapy (nivolumab plus ipilimumab), and the study focuses on the role of surgery in the “immuno-oncology era.”
SeoulAges 18 years+ - NCT05738525Recruiting
Compare two types of home dialysis for kidney outcomes and quality of life
This study compares two forms of home peritoneal dialysis—how well they work for kidney health and how they affect daily life. You may be considered if you have end-stage kidney disease and meet specific test and safety requirements.
Beijing, Beijing MunicipalityAges 18–75 - NCT04643106Recruiting
Compare two ways to stop bleeding during ovarian cyst removal
This trial compares two methods used during laparoscopic (small-robot/pinch-incision) ovarian cyst surgery to see which stops bleeding better and better protects future fertility. You may be eligible if you’re having surgery for ovarian endometriosis and meet hormone and pregnancy-related requirements.
Goyang-si, Gyeonggi-doAges 19–45
Common questions
- How many women’s health & pregnancy clinical trials are recruiting?
- Clin2 is tracking 6,071 recruiting obstetrics & gynecology studies from the U.S. registry right now, out of 9,764 we cover in this area in total.
- What does “Women’s health & pregnancy” cover here?
- Reproductive health, pregnancy, and conditions specific to women. We group each study into women’s health & pregnancy based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a women’s health & pregnancy trial near me?
- Use the search to filter women’s health & pregnancy studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.